Behbahani Ali
SEC Form 4 insider trading activity
Behbahani Ali has filed 11 SEC Form 4 filings (33 transaction rows) across 5 companies, including CRSP, BDTX, GLUE, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Sep 21, 2026.
On the most recent filing, Behbahani Ali is listed as Director at CRISPR Therapeutics AG. Inside the rolling window, Behbahani Ali reported 1 open-market purchase totaling $15.0M in SGP and 1 open-market sale totaling $781K in CRSP. The largest disclosed transaction in the window is a purchase of 937,500 SGP shares on Feb 9, 2026, worth $15.0M.
Companies traded
Other insiders at CRSP
Insider Buying
$15.0M
reported purchases (SEC code P)
Insider Selling
$781K
reported sales (SEC code S)
Companies
5
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Behbahani Ali made?
Behbahani Ali has filed 11 SEC Form 4 filings (33 transaction rows) across 5 companies, including CRSP, BDTX, GLUE since 2025.
Which companies does Behbahani Ali trade?
Behbahani Ali has filed SEC Form 4 disclosures for 5 companies, including CRSP, BDTX, GLUE.
When was Behbahani Ali's most recent SEC Form 4 filing?
Behbahani Ali's most recent SEC Form 4 filing on Tracefour is dated Sep 21, 2026.
What is Behbahani Ali's total buy and sell value in the current window?
Inside the rolling retention window, Behbahani Ali bought $15.0M and sold $781K based on SEC Form 4 filings.
What was Behbahani Ali's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 937,500 SGP shares on 2026-02-09, worth $15.0M, per SEC Form 4 filings.